Drugs from marine sources: modulation of TRAIL induced apoptosis in cancer cells

Ammad Ahmad Farooqi1, Rukset Attar, Maria Luisa Gasparri

  • 1Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan

Insights

Marine microorganisms offer promising anticancer compounds that induce apoptosis in cancer cells. These natural agents can enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death through intrinsic and extrinsic pathways.

Area of Science:

  • Molecular oncology and marine biotechnology.
  • Exploration of natural products for cancer therapy.

Background:

  • Advances in high-throughput technologies reveal cancer progression mechanisms.
  • Marine microorganisms and plankton are recognized as sources of anticancer compounds.
  • Marine-derived compounds are crucial for inducing apoptosis in cancer cells.

Purpose of the Study:

  • To discuss marine-derived compounds that induce apoptosis.
  • To highlight the role of marine agents in enhancing TRAIL-induced apoptosis.
  • To explore the functionalization of intrinsic and extrinsic pathways by marine compounds.

Main Methods:

  • Review of scientific literature on marine-derived anticancer compounds.
  • Analysis of mechanisms by which marine compounds induce apoptosis.
  • Examination of agents that enhance TRAIL-induced apoptosis.

Main Results:

  • A list of marine-derived compounds with apoptosis-inducing properties is presented.
  • Marine agents demonstrate efficacy in enhancing TRAIL-induced apoptosis.
  • These compounds modulate both intrinsic and extrinsic apoptotic pathways.

Conclusions:

  • Marine-derived compounds represent a significant resource for developing novel anticancer therapeutics.
  • Targeting apoptosis pathways, particularly TRAIL-induced apoptosis, is a viable strategy in cancer treatment.
  • Further research into marine biodiversity can yield potent anticancer agents.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K